Valve disease due to appetite suppressants (cont'd).
(1) The risk of cardiac valve disease linked to appetite suppressants has now been confirmed by several studies. It seems to increase with the duration of treatment. (2) The outcome after treatment cessation is poorly known. (3) Patients exposed to these drugs should continue to be monitored.